Osteoporosis therapies for rheumatoid arthritis patients: minimizing gastrointestinal side effects.

Sewell, K; Schein, J R

Sewell, K; Schein, J R.

Affiliation

Sewell K; Division of Gerontology, Harvard Medical School, Boston, MA, USA.

Semin Arthritis Rheum ; 30(4): 288-97, 2001 Feb.

Article in En | MEDLINE | ID: mdl-11182029

Subject(s)

Arthritis, Rheumatoid/complications; Gastrointestinal Diseases/prevention & control; Osteoporosis/drug therapy; Alendronate/therapeutic use; Anti-Inflammatory Agents, Non-Steroidal/therapeutic use; Arthritis, Rheumatoid/drug therapy; Estrogen Replacement Therapy; Female; Gastrointestinal Diseases/chemically induced; Humans; Osteoporosis/etiology; Postmenopause; Raloxifene Hydrochloride/therapeutic use; Risk Factors

Search on Google

XML

PubMed Links

Collection: 01-internacional Database: MEDLINE Main subject: Osteoporosis / Arthritis, Rheumatoid / Gastrointestinal Diseases Type of study: Etiology_studies / Guideline / Prognostic_studies / Risk_factors_studies / Systematic_reviews Limits: Female / Humans Language: En Journal: Semin Arthritis Rheum Year: 2001 Type: Article Affiliation country: United States

Search on Google

XML

PubMed Links